Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Report Details Case of Hydrochlorothiazide-Induced Lupus
Envarsus XR Approved for New de novo Indication
Baricitinib Gets Fast Track Status for Systemic Lupus Erythematosus
Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury
Opioid Use High in Patients With Systemic Lupus Erythematosus
Jakafi Granted Priority Review for Acute Graft-Versus-Host Disease
Researchers Debate Hydroxychloroquine Dosing in SLE
Rituxan Labeling Updated With Follow Up Treatment Info for Patients With GPA/MPA
Product Availability Update for Gammaplex Immune Globulin
Posttransplant Outcomes Assessed in Patients Who Resumed TNFi Therapy
Treatment for WHIM Syndrome Gets Orphan Drug Designation
Adverse Effect of Osteoporosis Drug May Help Treat Hair Loss
Lupus Is a Leading Cause of Death in Young Women
Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus
Firdapse NDA Submitted for Lambert-Eaton Myasthenic Syndrome
Hizentra Approved for Chronic Inflammatory Demyelinating Polyneuropathy
Envarsus XR sNDA Seeking New Indication Submitted to FDA
Rituxan Granted Priority Review for Rare Autoimmune Disease
